```html

Pheochromocytoma Symptoms – What to Look For, How It’s Diagnosed, and What You Can Do

What is Pheochromocytoma symptoms?

Pheochromocytoma is a rare tumor that arises from chromaffin cells of the adrenal medulla (the inner part of the adrenal glands) or, less commonly, from extra‑adrenal paraganglia. These cells normally produce catecholamines—mainly adrenaline (epinephrine) and noradrenaline (norepinephrine). When a pheochromocytoma is present, it secretes excess catecholamines in an unpredictable fashion, leading to a characteristic pattern of symptoms.

Because the hormone surge can mimic everyday stress responses, the condition is often called “the great masquerader.” Recognizing the symptom cluster is essential; untreated pheochromocytoma can cause life‑threatening hypertension, cardiac arrhythmias, or stroke.

Sources: Mayo Clinic, National Institute of Health (NIH), American Association of Clinical Endocrinology.

Common Causes

While pheochromocytoma itself is the primary cause of its symptom complex, several underlying conditions increase the likelihood of developing the tumor or producing similar catecholamine‑related signs.

• Genetic Syndromes – Multiple endocrine neoplasia type 2 (MEN 2), von Hippel‑Lindau disease, neurofibromatosis type 1, and succinate dehydrogenase (SDH) gene mutations.
• Familial Pheochromocytoma – Autosomal‑dominant inheritance without a broader syndrome.
• Extra‑adrenal paragangliomas – Tumors arising from sympathetic ganglia that also secrete catecholamines.
• Adrenal cortical adenoma or carcinoma – Can coexist and complicate the clinical picture.
• Chronic hypoxia – High‑altitude living or chronic lung disease can stimulate catecholamine production.
• Renal artery stenosis – Secondary hyper‑reninemic hypertension may mimic catecholamine excess.
• Medications that increase catecholamine activity – Certain decongestants, stimulants, or illicit drugs (e.g., cocaine, amphetamines).
• Stress‑induced catecholamine surges – Severe emotional or physical stress can unmask a previously silent tumor.
• Pregnancy – Hormonal changes may precipitate tumor growth or symptom manifestation.
• Other rare tumors – E.g., medullary thyroid carcinoma (often part of MEN 2) can coexist and share symptom overlap.

Associated Symptoms

The hallmark of pheochromocytoma is the episodic “spells” of catecholamine excess. Symptoms can be brief (minutes) or last several hours, and they may vary from day to day.

• High blood pressure – Often paroxysmal, can reach hypertensive crisis levels (>180/120 mm Hg).
• Rapid heart beat (tachycardia) or palpitations – May feel like a fluttering or pounding.
• Headache – Sudden, severe, throbbing, often described as “worst headache of my life.”
• Sweating (diaphoresis) – Profuse, may be cold and clammy.
• Palmar or plantar pallor – Due to vasoconstriction.
• Anxiety or panic‑like episodes – Feelings of impending doom, trembling.
• Chest pain or tightness – May mimic angina.
• Abdominal or back pain – Sometimes the initial clue.
• Weight loss – Unexplained, due to increased metabolic rate.
• Blurred vision or visual disturbances – From severe hypertension.
• Feeling of “near‑syncope” (light‑headedness) – Resulting from sudden blood pressure swings.

When to See a Doctor

Because the symptoms overlap with far more common conditions (e.g., anxiety, essential hypertension), it’s important to recognize red‑flag patterns that warrant prompt medical evaluation.

• Episodes of severe headache, sweating, and palpitations that occur together.
• Sudden spikes in blood pressure that are difficult to control with usual medications.
• Family history of pheochromocytoma or related genetic syndromes.
• Unexplained high blood pressure in a young adult (<40 years).
• New‑onset hypertension during pregnancy accompanied by classic “spell” symptoms.
• Persistent anxiety or panic attacks that do not improve with standard therapy.

If any of these patterns appear, schedule a medical appointment promptly. Early detection reduces the risk of cardiovascular complications.

Diagnosis

Diagnosing pheochromocytoma involves biochemical confirmation of excess catecholamines followed by imaging to locate the tumor.

1. Biochemical Testing

• Plasma free metanephrines – Most sensitive test; drawn after the patient has been supine for at least 30 minutes.
• 24‑hour urinary fractionated metanephrines and catecholamines – Useful when plasma testing is unavailable.
• Chromogranin‑A – May be elevated, supporting the diagnosis.

2. Imaging Studies

• CT (computed tomography) scan of the abdomen and pelvis – First‑line for locating adrenal masses.
• MRI (magnetic resonance imaging) – Preferred in patients with contrast allergy or to better characterize soft‑tissue lesions.
• ^123I‑MIBG scintigraphy – Functional imaging that highlights catecholamine‑producing tissue; valuable for extra‑adrenal or metastatic disease.
• ^18F‑FDG PET/CT or ^68Ga‑DOTATATE PET – Advanced imaging for elusive or metastatic tumors.

3. Genetic Testing

Because up to 40 % of pheochromocytomas have a hereditary basis, genetic counseling and testing for RET, VHL, NF1, SDHB, SDHD, and other relevant genes are recommended, especially in patients under 45 years or with a positive family history.

4. Pre‑operative Preparation

Before any surgery, patients must be medically stabilized with alpha‑adrenergic blockade (e.g., phenoxybenzamine) for 10–14 days, followed by beta‑blockade if tachycardia persists. This reduces the risk of intra‑operative hypertensive crises.

Treatment Options

Management combines definitive tumor removal with supportive medical therapy.

Surgical Treatment

• Laparoscopic adrenalectomy – Preferred for most adrenal pheochromocytomas; offers quicker recovery.
• Open adrenalectomy – Reserved for large (>6 cm), invasive, or malignant tumors.
• Resection of extra‑adrenal paragangliomas – May require more extensive vascular control.

Medical Management (when surgery is delayed or not possible)

• Alpha‑blockers – Phenoxybenzamine (non‑selective, irreversible) or doxazosin/terazosin (selective). Controls blood pressure and prevents catecholamine‑induced vasoconstriction.
• Beta‑blockers – Propranolol or metoprolol added after adequate alpha blockade to manage tachycardia.
• Calcium channel blockers – Amlodipine or nicardipine may be adjuncts for resistant hypertension.
• Methylene blue – Occasionally used in refractory hypertensive crises.

Post‑operative Care

• Monitor blood pressure closely; hypotension is common once catecholamine source is removed.
• Check plasma/urine metanephrines at 2‑weeks and again at 6‑months to confirm cure.
• Long‑term follow‑up for genetic carriers, as recurrence or new tumors can develop.

Home & Lifestyle Measures

• Maintain a low‑sodium diet (<2 g/day) to support blood‑pressure control.
• Avoid triggers that provoke catecholamine release: caffeine, nicotine, alcohol, and high‑intensity exercise until medically cleared.
• Practice stress‑reduction techniques (deep breathing, yoga) which may lessen the frequency of spells.
• Keep a symptom diary noting time, triggers, blood pressure, and heart rate – valuable for your physician.

Prevention Tips

Because most pheochromocytomas are sporadic, true primary prevention is limited. However, the following strategies can reduce risk or facilitate early detection:

• Family screening – If a first‑degree relative has a diagnosed pheochromocytoma or a known hereditary syndrome, undergo genetic counseling and periodic biochemical testing.
• Routine surveillance for high‑risk groups – Patients with MEN 2, VHL, NF1, or SDH mutations should have annual plasma metanephrine measurements starting in childhood.
• Control known secondary causes of hypertension – Treat renal artery stenosis, obstructive sleep apnea, and endocrine disorders promptly.
• Avoid known pharmacologic triggers – Discuss any over‑the‑counter decongestants or stimulant medications with your doctor.
• Healthy lifestyle – Regular moderate exercise, balanced diet, and weight management support overall cardiovascular health.

Emergency Warning Signs

Bottom Line

Pheochromocytoma is a rare but potentially deadly tumor that releases excess adrenaline‑type hormones. Recognizing the classic symptom triad—headache, sweating, and palpitations—along with paroxysmal hypertension is key. Prompt biochemical testing, imaging, and surgical removal are the cornerstones of care, while alpha‑blockade protects patients from dangerous blood‑pressure spikes. If you fit any high‑risk profile or notice the warning signs, do not wait—consult a healthcare professional.

For further reading, see:

• Mayo Clinic. Pheochromocytoma and Paraganglioma. https://www.mayoclinic.org
• National Institute of Health (NIH) – Office of Rare Diseases. Pheochromocytoma. https://rarediseases.info.nih.gov
• American Association of Clinical Endocrinology. Guidelines for the Diagnosis and Management of Pheochromocytoma, 2023.
• World Health Organization (WHO). International Classification of Diseases – Pheochromocytoma, ICD‑11.

```